Published Date: 12/16/2022
Expiration Date: 04/19/2025
This course will provide attendees with a definition of sustained virologic response (SVR) and how it progresses in a person living with HCV. Clinicians will gain knowledge on how to manage cirrhotic patients post-SVR. This course will also help clinicians understand populations that are at-risk for HCV reinfection.
David E. Bernstein, MD, MACG, FAGA, FACP, FAASLD is an internationally known gastroenterologist, hepatologist. Currently, he is the President of JSDB Medical Consulting, LLC and David Bernstein, MD, PC. Dr. Bernstein graduated from SUNY-Stony Brook School of Medicine, completed his medical residency at Montefiore Medical Center and his fellowship in Gastroenterology and Hepatology at the University of Miami Affiliated Hospitals under the direction of Dr. Eugene Schiff. He was the Chief of Gastroenterology at Winthrop Hospital and the Chief of Gastroenterology for Long Island Jewish Hospital and North Shore University Hospital. Most recently, he was the Head of the Liver Sub-Specialty Service Line, Vice Chair of Clinical Trials, Chief, Division of Hepatology, and Director of the Sandra Atlas Bass Center for Liver Diseases for the Northwell Health System. He was a Professor of Medicine and Educational Science at the Zucker School of Medicine at Hofstra/Northwell. Dr. Bernstein’s research interests primarily in the management and treatment of liver diseases, with most of his work concentrated on developing new treatments for viral hepatitis, primary biliary cholangitis and fatty liver disease. He has also worked to develop new agents for procedural sedation. Dr Bernstein has authored or co-authored more than 300 original scientific manuscripts, reviews, book chapters and abstracts. He has been the principal investigator in more than 200 clinical trials. He is a sought after lecturer who has is frequently invited to speak at venues across the United States and around the world. Dr. Bernstein has been involved in shaping public policy and education regarding liver diseases in New York State. He served as a special consultant to the New York State Department of Health and in that role has helped develop and implement New York State’s 5-year Strategic Plan for Viral Hepatitis as well as work with the group developing the guidelines used for the treatment of hepatitis C in New York State. He regularly leads telemedicine conferences for public health providers, prison health providers and federally qualified health care centers to educate these providers and has made himself available as a special consultant to these centers for individual case questions.